0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Recent publications

Prospective characterisation of drug-resistant bloodstream infections in Africa and Asia (ACORN2): a surveillance network assessment.Hopkins, J. Lee, S. J. Waithira, N. Painter, C. Ling, C. L. Roberts, T. Miliya, T. Obeng-Nkrumah, N. Opintan, J. A. Abbeyquaye, E. P. Hamers, R. L. Saharman, Y. R. Sinto, R. Karyanti, M. R. Ibrahim, R. F. Akech, S. O. Ashley, E. A. Douangnouvong, A. Choumlivong, K. Feasey, N. A. Kululanga, D. Lissauer, S. Karkey, A. Kunwar, N. Erakhaiwu, J. E. Okeke, I. N. Adebiyi, I. Adekanmbi, O. A. Oduola, A. B. Ogunbosi, B. O. Ojifinni, K. A. Tongo, O. O. Ude, I. A. Aboderin, A. O. Adekanle, O. Adeyemo, A. T. Edward, S. S. Osagie, U. Nguyen, T. H. Pham, N. T. Tran, V. G. Hoang, T. L. H. Trinh, H. T. van Doorn, H. R. Turner, P. Acorn Investigators
Lancet Microbe, (2026). 7:101228

External Validation of Pediatric Pneumonia and Bronchiolitis Risk Scores to Predict Mortality in Children Hospitalized in Kenya: A Retrospective Cohort Study.Gordon, B. Nyiro, J. U. Nair, H. Sheikh, Z. Katama, E. Agoti, C. N. Pei, R. Zar, H. Shi, T.
J Infect Dis, (2026). 233:e230-e238

Serotype-specific pneumococcal invasiveness: a global meta-analysis of paired estimates of disease incidence and carriage prevalence.Gallagher, K. E. Odiwour, F. Bottomley, C. Ojal, J. Adamu, A. Muthumbi, E. Kagucia, E. W. Hammitt, L. L. Massora, S. Sigauque, B. Chauque, A. Vilanculos, L. Verani, J. R. da Gloria Carvalho, M. von Gottberg, A. Kleynhans, J. Madhi, S. A. Olwagen, C. P. Mackenzie, G. Salaudeen, R. Gierke, R. Kobayashi, M. Pelton, S. Yildirim, I. Thomas, S. Tunali, A. Farley, M. Swarthout, T. D. Kalizang'oma, A. Heyderman, R. S. French, N. Choi, Y. Andrews, N. Ladhani, S. Miller, E. Scott, J. A. G.
Lancet Microbe, (2026). 7:101301

Bringing together realist and economic approaches in the evaluation of health and social care interventions: a scoping review of theoretical, methodological and practical implications.Fletcher, A. Dalkin, S. Anderson, R. Baker, R. M. Donaldson, C. Hibberd, V. Kumar, M. B. Shenton, F. Westhorp, G. Wong, G. Wright, J. Bate, A.
Soc Sci Med, (2026). 393:119050

Tackling the global hypertension crisis.Etyang, A. O. Jobe, M. Abdalla, M. Murphy, A.
BMJ, (2026). 392:s367

USP25 in genetic generalized epilepsy: a gene under scrutiny.Erfanian Omidvar, M. Murrell, J. R. Prentice, A. J. Helbig, I. Lerche, H. May, P. Epi, Collaborative
Brain, (2026). 149:e16-e18

Time for change in implementation research and practice.English, M. McKnight, J. Molyneux, S. Vincent, C. Fuller, S.
BMC Med, (2026). 24:

Beyond poverty, tungiasis is associated with family characteristics and parenting behavior: a case control study in Kenya.Elson, L. Matharu, A. K. Otieno, B. Riithi, N. Ouma, P. Mutebi, F. Waiswa, C. Feldmeier, H. Abubakar, A. Krucken, J. Fillinger, U.
BMC Public Health, (2026). 26:540

Individual and household factors associated with tungiasis in a marginalized population in Karamoja, northeastern Uganda.Elson, L. Matharu, A. K. Otieno, B. Feldmeier, H. Waiswa, C. Abubakar, A. Krucken, J. Fillinger, U. Mutebi, F.
Trop Med Health, (2026). 54:

HepB-boost: Implementation of free-of-charge health care worker hepatitis B testing and vaccination at Kilifi County Referral Hospital, Kenya.Downs, L. O. Tinga, L. Andersson, M. I. Matthews, P. C. Madia, J. Gathua, L. Tajbhai, M. U. Kagwanja, N. Aliyan, N.
Int J Infect Dis, (2026). 164:108418

HepB-boost: Implementation of free-of-charge health care worker hepatitis B testing and vaccination at Kilifi County Referral Hospital, Kenya.Downs, L. O. Tinga, L. Andersson, M. I. Matthews, P. C. Madia, J. Gathua, L. Tajbhai, M. U. Kagwanja, N. Aliyan, N.
Int J Infect Dis, (2026). 164:108418

Ultrasound in Extracorporeal Membrane Oxygenation: An ELSO State-of-the-Art Review.Doufle, G. O'Neil, E. R. Abreu, S. Aljassim, N. A. Di Nardo, M. Obonyo, N. G. Pinzon, V. Price, S. Ramanathan, K. Balik, M.
ASAIO J, (2026). 72:85-98

Viral diversity influences T-cell responses to enteric human adenoviruses F40 and F41.Craven, H. M. Hoang, J. P. Mukhopadhyay, R. Lambisia, A. W. Krishna, B. A. C. Ravenhill, B. J. Agoti, C. N. Houldcroft, C. J.
Virus Evol, (2026). 12:veaf098

A cost-consequence analysis of the children's administration oxygenation strategies trial (COAST) in severe pneumonia.Carroll, O. U. Grieve, R. Kiguli, S. Olupot-Olupot, P. Opoka, R. O. Alaroker, F. Tagoola, A. Hamaluba, M. Nabawanuka, E. Nalwanga, D. Williams, T. N. Thomas, K. Harrison, D. A. Mouncey, P. Giallongo, E. Rowan, K. Maitland, K. Sadique, Z.
PLOS Glob Public Health, (2026). 6:e0005654

Implementing a change process to support respectful communication in newborn units in Kenya: A qualitative study.Boga, M. Musitia, P. Oluoch, D. Sen, D. Dayo, H. Haaland, A. Hinton, L. Nzinga, J. English, M. Molyneux, S.
Int J Nurs Stud, (2026). 173:105236

Gut microbial diversity impacts carbohydrate fermentation by children with severe acute malnutrition.Bisht, A. Ahn-Jarvis, J. Corbin, K. Harris, S. Troncoso-Rey, P. Olupot-Olupot, P. Calder, N. Walsh, K. Maitland, K. Frost, G. Warren, F. J.
iScience, (2026). 29:114640

Predicting off-track development in infants aged 0-6 months in low-resource settings using machine learning.Benson, F. N. Odhiambo, R. Ngugi, A. K. Brink, W. Waljee, A. K. Moyer, C. A. Zhu, J. Agoi, F. Abubakar, A.
Pediatr Res, (2026). :

Pharmacokinetics and safety of fosfomycin and flomoxef administered as part of neonatal sepsis treatment (NeoSep1 Part 1).Bekker, A. Panjasawatwong, N. Hill, L. F. Stohr, W. Walker, A. S. Ellis, S. Dramowski, A. Whitelaw, A. Obiero, C. Berkley, J. A. Makazi, A. Velaphi, S. Thomas, R. Magagula, P. Abrahams, I. Nakwa, F. L. Barday, M. M. Van Kwawegen, A. Pillay, K. Gastine, S. Standing, J. F. Skoutari, P. Schiavone, F. Sharland, M. O'Brien, S. Bielicki, J. A. Cressey, T. R. NeoSep Study, Team
Antimicrob Agents Chemother, (2026). 70:e0112625

Safety, tolerability, and immunogenicity of the ChAdOx1 RVF vaccine against Rift Valley fever among healthy adults in Uganda: a single-centre, single-blind, randomised, placebo-controlled, dose-escalation, phase 1 trial.Anywaine, Z. Serwanga, J. Ggayi, A. M. Abaasa, A. M. Wright, D. Gombe, B. Ejou, P. Namata, T. Kigozi, A. Tukamwesiga, N. Basajja, V. Ankunda, V. Mulondo, D. J. Nambaziira, F. Kakande, A. Kakeeto, W. Nabaggala, P. Jenkin, D. Lawrie, A. Folegatti, P. Tran, N. Hansen, C. Elliott, A. M. Hill, A. V. S. Warimwe, G. M. Kaleebu, P.
Lancet Infect Dis, (2026). 26:302-313

Level and determinants of district primary healthcare system technical efficiency in Ghana: two-stage stochastic frontier analysis.Amboko, B. Novignon, J. Muthuri, Rndk Bozzani, F. M. Vassall, A. Barasa, E.
BMJ Glob Health, (2026). 11: